BlueIO
VC Fund
Burlington, United States
BlueIO is an investment firm that prefers to invest in the healthcare, technology, and consumer goods sectors. The firm was founded in 2012 by Dave Furneaux and is based in Boston, Massachusetts, United States.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries BlueIO invests in
Stages BlueIO invests in
Countries BlueIO invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alison Furneaux
|
|||
Jan Haas
|
|||
Justin Deckert
|
|||
Justin Deckert
|
Investment Focus
Industry
- Software 2 (33%)
- Cyber Security 2 (33%)
- FinTech 1 (17%)
- Finance 1 (17%)
- Medical 1 (17%)
Stage
- Series C 2 (33%)
- Seed 1 (17%)
- Series A 1 (17%)
- Series B 1 (17%)
- Funding Round 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Dave Furneaux
Founder, Chairman and CEO
|
Founder, Chairman and CEO | Total investments: 23 | Find email | |
|
Alison Furneaux
Operating Partner
|
Operating Partner | Total investments: 0 | Find email | |
|
Jan Haas
President
|
President | Total investments: 0 | Find email | |
|
Justin Deckert
Chief of Staff
|
Chief of Staff | Total investments: 0 | Find email | |
|
Justin Deckert
Chief of Staff
|
Chief of Staff | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CyberSaint Security
|
CyberSaint is an innovative company delivering the only platform to support the convergence of security operations, continuous compliance, and risk management. CISOs of the Fortune 500 rely on CyberSaint's CyberStrong platform to achieve real-time risk management and continuous compliance from assessment to Boardroom. CyberStrong empowersCISOs, CIOs, cyber risk professionals and IT compliance teams to mitigate even the most unprecedented risks while automating control compliance assessments at scale. Hundreds of customers leverage CyberStrong to standardize on frameworks and standards, implement risk quantification, and communicate their real-time cybersecurity posture- leading to faster, more informed decision-making at the executive level and millions in cost-savings.CyberSaint’s patented AI and Lachine learning technology and unique approach to cyber and IT risk management has resulted in industry recognition. CyberSaint is a Gartner Cool Vendor and has won numerous awards including 2021 CRN Emerging Vendor, 2021 Cybersecurity Excellence Award Gold Winner, and 2021 Cyber Defense Magazine Global InfoSec Awards Winner for Integrated Risk Management and Cyber Risk Management. | $21M / Series A / Mar 20, 2024 | |
Virsec
|
At Virsec, we know a protection-first cybersecurity model is possible. By making server workloads self-protecting, we offer continuous protection, stopping known and unknown attacks—including zero days. With our revolutionary, patented technology, we secure software from the inside at runtime, precisely mapping what the app can do and stoppingmalicious code before it can run. Battle-tested against 200+ of the top government red-teamers and trusted by several Fortune100 companies, Virsec has repeatedly proven a protection-first model works. Virsec is headquartered in San Jose, California, with offices worldwide. | $100M / Series C / Jul 14, 2021 | |
Ourly
|
Ourly is a digital allowance platform for banks that provides tools to remove the friction that parents and kids struggle with regarding money matters. Their best-in-breed SaaS platform empowers financial institutions to “turn on” financial literacy as a youth banking solution – standalone or integrated. | $2.6M / Seed / Sep 16, 2019 | |
|
CyberSaint Security
|
CyberSaint is an innovative company delivering the only platform to support the convergence of security operations, continuous compliance, and risk management. CISOs of the Fortune 500 rely on CyberSaint's CyberStrong platform to achieve real-time risk management and continuous compliance from assessment to Boardroom. CyberStrong empowersCISOs, CIOs, cyber risk professionals and IT compliance teams to mitigate even the most unprecedented risks while automating control compliance assessments at scale. Hundreds of customers leverage CyberStrong to standardize on frameworks and standards, implement risk quantification, and communicate their real-time cybersecurity posture- leading to faster, more informed decision-making at the executive level and millions in cost-savings.CyberSaint’s patented AI and Lachine learning technology and unique approach to cyber and IT risk management has resulted in industry recognition. CyberSaint is a Gartner Cool Vendor and has won numerous awards including 2021 CRN Emerging Vendor, 2021 Cybersecurity Excellence Award Gold Winner, and 2021 Cyber Defense Magazine Global InfoSec Awards Winner for Integrated Risk Management and Cyber Risk Management. | $3M / May 29, 2018 | |
|
Virsec
|
At Virsec, we know a protection-first cybersecurity model is possible. By making server workloads self-protecting, we offer continuous protection, stopping known and unknown attacks—including zero days. With our revolutionary, patented technology, we secure software from the inside at runtime, precisely mapping what the app can do and stoppingmalicious code before it can run. Battle-tested against 200+ of the top government red-teamers and trusted by several Fortune100 companies, Virsec has repeatedly proven a protection-first model works. Virsec is headquartered in San Jose, California, with offices worldwide. | $27.1M / Series B / Mar 20, 2018 | |
Lumicell
|
Lumicell is specializing in the field of image-guided cancer surgery. The company's technology illuminates cancer cells in the tumor cavity, enabling physicians to take action in real-time to improve patient outcomes. The company's lead product, consisting of a fluorescent optical contrast agent and a handheld illumination device, iscurrently under clinical investigation in patients undergoing breast cancer surgery. A planned pivotal study aims to evaluate the ability of the technology to reduce positive margin rates and reduce repeat surgeries while sparing healthy tissue. Lumicell technology is also being investigated in colorectal cancer, Barrett’s Esophagus, pancreatic cancer, and brain metastases. In clinical studies to date, no cancer has been missed and the safety profile of the optical contrast agent has been demonstrated.Lumicell was founded in 2008 and is based in Newton, MA, USA. | $28.7M / Series C / Oct 24, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does BlueIO invest in?
BlueIO invests primarily in Software, Cyber Security and FinTech startups, most often at Series C and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BlueIO?
Public channels for BlueIO include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BlueIO?
The team at BlueIO includes Dave Furneaux (Founder, Chairman and CEO), Alison Furneaux (Operating Partner) and Jan Haas (President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
